Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-22

Clinical Trial Update: A Drug Interaction Study With Albiglutide and Warfarin [Phase 1]

View source ↗

Summary

A Phase 1 trial update reports the results of a drug interaction study between albiglutide and warfarin in people with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tanzeum (Albiglutide)
  • Warfarin (warfarin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED